
    
      A Postmarketing Requirement Protocol, multicenter, open-label study in pediatric subjects 6
      months to 4 years of age with an active head lice infestation designed to determine the
      topical absorption and safety of Natroba (spinosad) Topical Suspension, 0.9% for a single, 10
      minute treatment for spinosad (Spinosyn A and Spinosyn D) and benzyl alcohol.
    
  